GLYC Insider Trading Activity and SEC Form 4 Filings
GLYC insider trading summary
No open-market insider purchases or sales of Glycomimetics Inc (GLYC) have been reported on SEC Form 4 in the past 12 months.
Latest GLYC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 8, 2024 | Siren, L.L.C. | Insider | Sell | $50K (260,873 @ $0.19) |
| Aug 8, 2024 | Invus Public Equities, L.P. | Insider | Sell | $50K (260,873 @ $0.19) |
| Aug 8, 2024 | Raymond Debbane | Insider | Sell | $50K (260,873 @ $0.19) |
| Aug 8, 2024 | Invus Public Equities Advisors, LLC | Insider | Sell | $50K (260,873 @ $0.19) |
| Aug 8, 2024 | Invus Global Management, LLC | Insider | Sell | $50K (260,873 @ $0.19) |
| Aug 7, 2024 | Siren, L.L.C. | Insider | Sell | $11K (61,488 @ $0.18) |
| Aug 7, 2024 | Invus Global Management, LLC | Insider | Sell | $11K (61,488 @ $0.18) |
| Aug 7, 2024 | Invus Public Equities, L.P. | Insider | Sell | $11K (61,488 @ $0.18) |
| Aug 7, 2024 | Raymond Debbane | Insider | Sell | $11K (61,488 @ $0.18) |
| Aug 7, 2024 | Invus Public Equities Advisors, LLC | Insider | Sell | $11K (61,488 @ $0.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.